ZYDUS LIFESCIENCES
Back to Income Statement
|
ZYDUS LIFESCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹3,860 Cr | ₹1,960 Cr | ₹4,487 Cr | ₹2,134 Cr | ₹1,177 Cr |
What is the latest Consolidated Net Profit of ZYDUS LIFESCIENCES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹3,860 Cr |
Mar2023 | ₹1,960 Cr |
Mar2022 | ₹4,487 Cr |
Mar2021 | ₹2,134 Cr |
Mar2020 | ₹1,177 Cr |
How is Consolidated Net Profit of ZYDUS LIFESCIENCES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹3,860 Cr | 96.88 | |
Mar2023 | ₹1,960 Cr | -56.31 | |
Mar2022 | ₹4,487 Cr | 110.32 | |
Mar2021 | ₹2,134 Cr | 81.34 | |
Mar2020 | ₹1,177 Cr | - |
Compare Consolidated Net Profit of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹95,805.3 Cr | 0.6% | -5.3% | 51% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹422,271.0 Cr | -0.9% | -4.8% | 50.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,183.0 Cr | 3% | 5.9% | 65% | Stock Analytics | |
CIPLA | ₹120,605.0 Cr | 1.5% | 0.1% | 19.9% | Stock Analytics | |
MANKIND PHARMA | ₹103,515.0 Cr | 0.6% | 3.1% | 34.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,869.0 Cr | -0.4% | -8.2% | 7.1% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | 0.6% |
-5.3% |
51% |
SENSEX | 3.5% |
-0.1% |
21.9% |
You may also like the below Video Courses